Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,787 | 126,039 | 56,445 | 101,292 | 272,277 |
| Marketable Securities | 265,971 | 234,981 | 166,434 | 193,860 | 125,290 |
| Other current assets | 471 | 502 | 502 | 502 | 419 |
| TOTAL | $383,793 | $365,262 | $228,154 | $300,398 | $402,611 |
| Non-Current Assets | |||||
| PPE Net | 69,971 | 64,681 | 57,967 | 48,626 | 34,462 |
| Investments And Advances | 52,113 | 106,883 | 137,463 | 106,601 | 43,516 |
| Other Non-Current Assets | 26,707 | 13,482 | 13,791 | 14,100 | 15,041 |
| TOTAL | $148,791 | $185,046 | $209,221 | $169,327 | $93,019 |
| Total Assets | $532,584 | $550,308 | $437,375 | $469,725 | $495,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,451 | 857 | 2,019 | 966 | 966 |
| Accounts payable and accrued liabilities | 4,048 | 9,893 | 7,596 | 11,644 | 13,427 |
| Accrued Expenses | 7,246 | 4,847 | 6,040 | 7,258 | 6,832 |
| TOTAL | $21,569 | $21,976 | $15,655 | $19,868 | $21,225 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,721 | 11,488 | 10,923 | 12,119 | 12,056 |
| Deferred Revenues | 7,824 | 6,379 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 30,433 | 14,430 | 14,559 | 14,750 | 14,752 |
| TOTAL | $153,063 | $141,668 | $25,482 | $26,869 | $26,808 |
| Total Liabilities | $174,632 | $163,644 | $41,137 | $46,737 | $48,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,882 | 58,850 | 58,819 | 54,641 | 54,404 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -456,667 | -425,679 | -388,166 | -359,972 | -333,963 |
| Other shareholders' equity | -3,434 | -2,642 | -650 | -63 | -3 |
| TOTAL | $357,952 | $386,664 | $396,238 | $422,988 | $447,597 |
| Total Liabilities And Equity | $532,584 | $550,308 | $437,375 | $469,725 | $495,630 |